Back to Top

There is a Mary Ann Liebert at Mary Ann Liebert, Inc. and that makes a difference.

For Immediate Release

Advances in Alzheimer’s Disease Reported in New Issue of Brain Connectivity

Contact: Kathryn Ryan
914-740-2250
kryan@liebertpub.com

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com

New Rochelle, NY, May 4, 2021—New advances in understanding Alzheimer’s disease based on functional connectivity and neural networks are published in a Special Issue on Alzheimer’s Disease in Brain Connectivity, a peer-reviewed journal from Mary Ann Liebert, Inc., publishers. Click here to read the article now.

Beau Ances, Washington University in St. Louis, and coauthors, evaluated global resting-state functional connectivity signature in mutation carriers from the Dominantly Inherited Alzheimer Network. They assessed the global resting-state functional connectivity with regards to amyloid, tau, and neurodegeneration biomarkers and estimated years to symptom onset. They present their findings in the article entitled “Resting-State Function Connectivity Disruption as a Pathological Biomarker in Autosomal Dominant Alzheimer Disease.”

Anna Weller and Alexander Drzezga, University of Cologne, together with their colleagues, contributed the article “Finding New Communities: A Principle of Neuronal Network Reorganization in Alzheimer’s Disease.” They focused on the Neuronal Network Reorganization in Alzheimer’s disease that the community structure of human functional connectome in AD are re-organized, with nodes changing their allegiance to communities.

In “The Influence of Cerebral Small Vessel Disease on Static and Dynamic Function Network Connectivity in Subjects Along Alzheimer’s Disease Continuum,” Minming Zhang, The 2nd Affiliated Hospital of Zhejiang University School of Medicine, and coauthors, evaluated the influence of cerebral small vessel disease on the brain functional connectivity in subjects along the Alzheimer’s disease continuum. They showed that neuropathology and cerebral small vessel disease burden divergently affect the functional network connectivity changes.

“This is an exciting time in the field of Alzheimer’s disease, with more advances in imaging and potential treatments on the way. It is also a challenging time considering the impact of COVID-19 on cognition and mental health. Brain Connectivity is determined to advance research in this field to prevent and achieve effective treatments for this incurable disease,” states Paul Edison, MD, PhD, Editor-in-Chief, Brain Connectivity, from Imperial College London.

About the Journal
Brain Connectivity is the essential peer-reviewed journal covering groundbreaking findings in the rapidly advancing field of connectivity research at the systems and network levels. Published 10 times per year in print and online, the Journal is under the leadership of Editor-in-Chief Paul Edison, MD, PhD, Imperial College London, U.K. It includes original peer-reviewed papers, review articles, point-counterpoint discussions on controversies in the field, and a product/technology review section. To ensure that scientific findings are rapidly disseminated, articles are published Instant Online within 72 hours of acceptance, with fully typeset, fast-track publication within 4 weeks. Tables of content and a sample issue may be viewed on the Brain Connectivity website.

About the Publisher
Mary Ann Liebert, Inc., publishers is known for establishing authoritative medical and biomedical peer-reviewed journals. Its biotechnology trade magazine, GEN (Genetic Engineering & Biotechnology News), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s more than 100 journals, newsmagazines, and books is available on the Mary Ann Liebert, Inc., publishers website.

Mary Ann Liebert, Inc.
140 Huguenot Street
New Rochelle, NY 10801
(914) 740-2100 or (800) M-LIEBERT
Fax (914) 740-2101
www.liebertpub.com